Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation

Acta Virologica

Volumn 50, Issue 4, 2006, Pages 243-249

  Lu, J H ^a,b   Long, J X ^a   Jia, L J ^a   Liu, Y L ^a   Shao, W X ^a   Zhang, Y M ^a   Liu, X F ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Avian influenza; Cleavage motif; Hemagglutinin; Influenza A virus; Neuraminidase; Phenotype; Reassortment; Reverse genetics; WSN strain

Indexed keywords

HEMAGGLUTININ; SIALIDASE; TRYPSIN;

ANIMAL EXPERIMENT; ARTICLE; AVIAN INFLUENZA; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENOME; INFLUENZA VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STABILITY; VIROGENESIS; VIRUS ISOLATION; VIRUS VIRULENCE; ZYGOTE;

ANIMALS; CELL LINE; CHICK EMBRYO; CHICKENS; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEURAMINIDASE; REASSORTANT VIRUSES; VIRAL PROTEINS; VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 33845934789     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alexander DJ, Spackman D (1981): Characterisation of influenza A viruses isolated from turkeys in England during March-May 1979. Avian Pathol. 10, 281-293.
2. Alexander DJ (2000): A review of avian influenza in different bird species. Vet. Microbiol. 74, 3-13.
3. Castrucci MR, Kawaoka Y (1993): Biologic importance of neuraminidase stalk length in influenza A virus. J. Virol. 67, 759-764.
4. Chen H, Deng G, Li Z, Tian G, Li Y, Jiao P, Zhang L, Liu Z, Webster RG, Yu K (2004): The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl. Acad. Sci. USA 101, 10452-10457.
5. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A (1999): Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679-9682.
6. Fouchier RAM, Munster V, Wallensten A, Bestebroer T M, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus ADME (2005): Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79, 2814-2822.
7. Goto H, Kawaoka Y (1998): A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. USA 95, 10224-10228.
8. Guan Y, Shortridge KF, Krauss S, Webster RG (1999): Molecular characterization of H9N2 influenza viruses: Were they the donors of the "internal" genes of H5N1 viruses in Hong Kong. Proc. Natl. Acad. Sci. USA 96, 9363-9367.
9. Guo YJ, Krauss S, Senne DA, Mo IP, Lo KS, Xiong XP, Norwood M, Shortridge KF, Webster RG, Guan Y (2000): Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineage in Asia. Virology 267, 279-288.
10. Hatta M, Gao P, Halfmann P, Kawaoka Y (2001): Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842.
11. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000): A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97, 6108-6113.
12. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001): Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146, 2275-2289.
13. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG (2002): Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20, 3165-3170.
14. Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA (1998): Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 244, 315-321.
15. Kawaoka Y, Krauss S, Webster RG (1989): Avian-to-human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J. Virol. 63, 4603-4608.
16. Li KS, Xu KM, Peiris JSM, Poon LLM, Yu KZ, Yuen KY, Shortridge KF, Webster RG, Guan Y (2003): Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans. J. Virol. 77, 6988-6994.
17. Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR (2003): Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314, 580-590.
18. Lu JH, Liu XF, Shao WX, Liu YL, Wei DP, Liu HQ (2005a): Phylogenetic analysis of eight genes of H9N2 subtype influenza virus: a mainland China strain possessing early isolates' genes that have been circulating. Virus Genes 31, 163-169.
19. Lu JH, Long JX, Shao WX, Wei DP, Liu XF (2005b): Generation of attenuated H5N1 and H5N2 subtype of influenza virus recombinants by reverse genetics. Wei Sheng Wu Xue Boo 45, 53-57.
20. Mayer V, Schulman JL, Kilbourne ED (1973): Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A/NWS (H0N1) influenza virus. J. Virol. 11, 272-278.
21. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y (2000): Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74, 6015-6020.
22. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y (1999): Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96, 9345-9350.
23. Office International des Epizooties (2000): Highly Pathogenic Avian Influenza. In Manual of Standards: Diagnostic tests and Vaccines. Paris, Office International des Epizooties, pp. 212-220.
24. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF (1999): Human infection with influenza H9N2. Lancet 354, 916-917.
25. Senne DA, Panigrahy B, Kawaoka Y, Pearson JE, Suss J, Lipkind M, Kida H, Webster RG (1996): Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis. 40, 425-437.
26. Steinhauer DA (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258, 1-20.
27. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, Brownlee G, Xu X, Lu X, Katz, J, Cox N, Matsuoka Y (2003): Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305, 192-200.
28. Wagner R, Wolff T, Herwig A, Pleschka S, Klenk HD (2000): Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenzavirus growth: A study by reverse genetics. J. Virol. 74, 6316-6323.
29. Webby RJ, Perez DR, Coleman JS, Guan Y, Knight J, Govorkova EA, McClain-Moss LR, Peiris JS, Reng JE, Tuomanen EI, Webster RG (2004): Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099-1103.
30. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992): Evolution and ecology of influenza A viruses. Microbiol. Rev. 56, 152-179.
31. Webster RG (2001): A molecular whodunit. Science 293, 1773-1775.